Description
Thrombin receptor agonist is a peptide that activates thrombin-mediated platelet aggregation signaling pathways; it mimics the effects of thrombin, activating protease-activated receptor-1 (PAR1) in wounds in vivo.
Product Unit Size | Cost | Quantity | Stock |
---|
Thrombin receptor agonist is a peptide that activates thrombin-mediated platelet aggregation signaling pathways; it mimics the effects of thrombin, activating protease-activated receptor-1 (PAR1) in wounds in vivo.
Cas No. | 137339-65-2 |
---|---|
Purity | ≥95% |
Formula | C81H118N20O23 |
Formula Wt. | 1739.96 |
Synonym | TRAP-14, TRAP |
Solubility | Soluble in water (0.9 mg/mL). |
Appearance | White to off white powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Windeløv NA, Sørensen AM, Perner A, et al. Platelet aggregation following trauma: a prospective study. Blood Coagul Fibrinolysis. 2014 Jan;25(1):67-73. PMID: 23945060.
Kreutz RP, Breall JA, Kreutz Y, et al. Protease activated receptor-1 (PAR-1) mediated platelet aggregation is dependent on clopidogrel response. Thromb Res. 2012 Aug;130(2):198-202. PMID: 22459907.
JAK2 inhibitor.
σ2 agonist.
Heterocyclic derivative of cysteine, alters pro...
Statin; HMG-CoA reductase inhibitor.
BK K+ channel and L-type Ca2+ channel blocker.<...
Cyclic dinucleotide that detects cytosolic DNA ...
Cyclic tetrapeptide; HDAC inhibitor.
STING inhibitor
Active form of vitamin D, regulates dietary Ca2...
HDAC inhibitor.
Mixture of kavalactones found in Piper methysti...
FAK inhibitor.
Non-depolarizing NMJ blocker; AChR antagonist.<...
LRRK2 inhibitor.
Synthetic peptide, vasopressin analog; AVPR1 ag...
PDE and adenosine deaminase inhibitor.
α7 nAChR partial agonist, 5-HT3 antagonist.
AT1 inhibitor.
Thienopyridine; P2Y12 antagonist.